ARTICLE | Distillery Therapeutics
Infectious disease
September 26, 2018 5:33 PM UTC
Patient sample and mouse studies suggest fungal CYP51 inhibitors and other antifungal agents could enhance the efficacy of fecal microbiotal transplants to treat Clostridium difficile infection (CDI)....
BCIQ Company Profiles
BCIQ Target Profiles
Fungal cytochrome P450 C-14 alpha demethylase (fungal CYP51)